The efficacy and safety of mizoribine in living donor kidney transplantation: A 24-week, open-label, prospective study (phase III clinical trial)

被引:6
|
作者
Cho, DK
Kim, JH
Park, SH
Kim, JC
Kim, CD
Baek, MY
Kim, SJ
Kim, SH
Kwon, TH
Kim, YL
Kim, YW
Chang, SK
机构
[1] Kyungpook Univ Hosp, Dept Internal Med, Jung Gu, Taegu, South Korea
[2] Kyungpook Univ Hosp, Dept Surg, Jung Gu, Taegu, South Korea
[3] Kyungpook Univ Hosp, Dept Urol, Jung Gu, Taegu, South Korea
关键词
D O I
10.1016/S0041-1345(01)02383-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:3256 / 3258
页数:3
相关论文
共 50 条
  • [1] Mizoribine in living donor kidney transplantation: Twenty four-week results of a single center, pre-randomized, open-label, prospective, comparative, phase III study
    Cho, DK
    Park, SH
    Kim, JC
    Kim, CD
    Baek, MY
    Kim, SJ
    Kim, JH
    Kim, SH
    Kwon, TH
    Kim, YL
    [J]. TRANSPLANTATION, 1999, 67 (07) : S154 - S154
  • [2] Efficacy and safety of galantamine in patients with dementia with Lewy bodies: A 24-week open-label study
    Edwards, Keith
    Royall, Donald
    Hershey, Linda
    Lichter, David
    Hake, Ann
    Farlow, Martin
    Pasquier, Florence
    Johnson, Stewart
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2007, 23 (06) : 401 - 405
  • [3] Efficacy and safety of efalizumab for scalp psoriasis: Results from a prospective, 24-week, open-label phase IIIb/IV clinical trial in patients from Latin America
    Takahashi, Maria Denise Fonseca
    Oliveira, Maria de Fatima
    Paramo, Antonio Vera
    Stengel, Fernando M.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB134 - AB134
  • [4] Efficacy and safety of repaglinide added to sitagliptin in Japanese patients with type 2 diabetes: A randomized 24-week open-label clinical trial
    Nishimura, Akihiro
    Usui, Shuki
    Kumashiro, Naoki
    Uchino, Hiroshi
    Yamato, Azusa
    Yasuda, Daijiro
    Nagasawa, Kaoru
    Okubo, Minoru
    Mori, Yasumichi
    Hirose, Takahisa
    [J]. ENDOCRINE JOURNAL, 2016, 63 (12) : 1087 - 1098
  • [5] An open-label, 24-week pilot study of the methyl donor betaine in Alzheimer disease patients
    Knopman, D
    Patterson, M
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2001, 15 (03): : 162 - 165
  • [6] Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease
    Holdstock, Louis
    Cizman, Borut
    Meadowcroft, Amy M.
    Biswas, Nandita
    Johnson, Brendan M.
    Jones, Delyth
    Kim, Sung Gyun
    Zeig, Steven
    Lepore, John J.
    Cobitz, Alexander R.
    [J]. CLINICAL KIDNEY JOURNAL, 2019, 12 (01) : 129 - 138
  • [7] Safety of efalizumab for the treatment of moderate to severe plaque psoriasis: A prospective 24-week, open-label phase IIIb/IV clinical trial in patients from Latin America
    Chouela, Edgardo
    Martins, Gladys Aires
    Cestari, Tania E.
    Hernandez, Maria Eugenia
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB134 - AB134
  • [8] Efficacy of efalizumab for the treatment of moderate to severe plaque psoriasis: A prospective, 24-week, open-label phase Mb/IV clinical trial in patients from Latin America
    Stengel, Fernando M.
    Chouela, Edgardo
    Takahashi, Maria Denise Fonseca
    Amaya, Mario
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB133 - AB133
  • [9] Efficacy and safety of efalizumab in adults with moderate to severe plaque psoriasis and hand and foot involvement: A prospective, 24-week, open-label phase IIIb/Iv clinical trial in patients from Latin America
    Cardenas, Engracia Lopez
    de Arruda, Lucia Favora
    Abulatia, Luna Azulay
    Gonzalez, Virgilio Santamaria
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB131 - AB131
  • [10] Efficacy, tolerability, and safety of oral paliperidone extended release in the treatment of schizophrenia: a 24-week, open-label, prospective switch study in different settings in Taiwan
    Chen, Ching-Yen
    Tang, Tze-Chun
    Chen, Tzu-Ting
    Bai, Ya Mei
    Tsai, Huei-Huang
    Chen, Hou-Liang
    Huang, Chun-Jen
    Chen, Chih-Ken
    Chen, Chun-Chih
    Hsiao, Mei-Chun
    Liu, Chia-Yih
    Yeh, Hong-Shiow
    Chiu, Nan-Ying
    Hsiao, Cheng-Chen
    Chen, Cheng-Sheng
    Su, Tung-Ping
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 725 - 732